SIENNA
T & D Diagnostics
Application Filed: 2020-07-21
Trademark Application Details
EX PARTE APPEAL PENDING
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90977927 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Alan F Feeney |
| Law Office Assigned | M80 |
| Employee Name | PIERCE, ALEXANDRA E |
Timeline
| 2020-05-00 | Date of First Use |
| 2020-07-21 | Application Filed |
| 2021-09-07 | Published for Opposition |
| 2022-07-20 | Status: Live/Pending |
| 2022-08-22 | Location: DIVISIONAL UNIT |
| 2022-08-22 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  T & D Diagnostics |
| Entity Statement | private limited company |
| Address | 219 Waverley Road, Suite 201 Dartmouth, Nova Sc CA B2X2C3 |
| Legal Entity Type | |
| Legal Entity State | CA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, respiratory tract infections including COVID-19, Influenza A, Influenza A + B, Strep A, Respiratory Syncytial Virus Antigen (RSV), Adenovirus pneumonia Antigen, Legionella pneumophilia, Streptococcus pneumoniae, Mycoplasma pneumonia Antigen and Antibody, Mononucleosis (MONO) and EBV VCA IgB and EBNA IgG; Diagnostic kits comprised of medical diagnostic assays for use in disease detection and screening related to COVID-19; Respiratory rapid tests, namely, diagnostic assays for use in performing respiratory rapid diagnostic tests for detecting COVID-19; Screening tests and devices to detect COVID-19 in a patient, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection related to COVID-19 |
| GS0051 | Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, respiratory tract infections including COVID-19, Influenza A, Influenza A + B, Strep A, Respiratory Syncytial Virus Antigen (RSV), Adenovirus pneumonia Antigen, Legionella pneumophilia, Streptococcus pneumoniae, Mycoplasma pneumonia Antigen and Antibody, Mononucleosis (MONO) and EBV VCA IgB and EBNA IgG; Diagnostic kits comprised of medical diagnostic assays for use in disease detection and screening related to COVID-19; Respiratory rapid tests, namely, diagnostic assays for use in performing respiratory rapid diagnostic tests for detecting COVID-19; Screening tests and devices to detect COVID-19 in a patient, namely, diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection related to COVID-19 |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2020-07-24 | 1 NWAP I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-07-25 | 2 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-07-25 | 3 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-07-25 | 4 TCCA I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-08-06 | 5 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-08-06 | 6 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-08-06 | 7 TCCA I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-08-18 | 8 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2021-02-05 | 9 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2021-02-12 | 10 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2021-02-12 | 11 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-02-12 | 12 GNRN O:Outgoing Correspondence |
| TEAS REQUEST TO DIVIDE RECEIVED | 2021-04-07 | 13 ERTD I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-04-07 | 14 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2021-06-21 | 15 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-06-29 | 16 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-06-29 | 17 TEME I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2021-07-28 | 18 AITU A:Allowance for Publication |
| DIVISIONAL REQUEST RECEIVED | 2021-04-07 | 19 DRRR I:Incoming Correspondence |
| DIVISIONAL PROCESSING COMPLETE | 2021-07-30 | 20 DPCC D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2021-08-02 | 21 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2021-08-02 | 22 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-08-02 | 23 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2021-08-02 | 24 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-08-02 | 25 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-08-18 | 26 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2021-09-07 | 27 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-09-07 | 28 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-11-02 | 29 NOAM E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2022-01-05 | 30 EISU I:Incoming Correspondence |
| USE AMENDMENT FILED | 2022-01-05 | 31 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2022-01-06 | 32 SUPC I:Incoming Correspondence |
| SU - NON-FINAL ACTION - WRITTEN | 2022-02-06 | 33 CNRT W: |
| NON-FINAL ACTION E-MAILED | 2022-02-06 | 34 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-02-06 | 35 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-02-16 | 36 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-02-17 | 37 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-02-17 | 38 TEME I:Incoming Correspondence |
| SU - FINAL REFUSAL - WRITTEN | 2022-04-02 | 39 CNFR W: |
| FINAL REFUSAL E-MAILED | 2022-04-02 | 40 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2022-04-02 | 41 GNFN O:Outgoing Correspondence |
| EXPARTE APPEAL RECEIVED AT TTAB | 2022-07-20 | 42 EXAF T:TTAB Proceeding |
| JURISDICTION RESTORED TO EXAMINING ATTORNEY | 2022-07-20 | 43 JURT T:TTAB Proceeding |
| EX PARTE APPEAL-INSTITUTED | 2022-07-20 | 44 EXPI T:TTAB Proceeding |
| TEAS REQUEST TO DIVIDE RECEIVED | 2022-07-20 | 45 ERTD I:Incoming Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2022-07-20 | 46 ERFR I:Incoming Correspondence |
| ASSIGNED TO LIE | 2022-07-27 | 47 ALIE A:Allowance for Publication |
| DIVISIONAL REQUEST RECEIVED | 2022-07-20 | 48 DRRR I:Incoming Correspondence |
| DIVISIONAL PROCESSING COMPLETE | 2022-08-22 | 49 DPCC D:Assigned to Examiner |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2022-10-30 | 50 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2022-11-01 | 51 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2022-12-06 | 52 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-12-06 | 53 NRCC E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 